Knight K , Wade S , Balducci L . Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am J Med 2004;116(Suppl 7A):11S–26S.
Birgegård G , Aapro MS , Bokemeyer C , et al.. Cancer-related anemia: pathogenesis, prevalence and treatment. Oncology 2005;68(Suppl 1):3–11.
Caro JJ , Salas M , Ward A , et al.. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer 2001;91:2214–2221.
Becker PS , Griffiths EA , Alwan, L , et al.. NCCN Clinical Practice Guidelines in Oncology: Hematopoietic Growth Factors. Version 2.2020. Accessed May 1, 2020. To view the most recent version, visit NCCN.org
Gilreath JA , Stenehjem DD , Rodgers GM . Diagnosis and treatment of cancer-related anemia. Am J Hematol 2014;89:203–212.
Prescott LS , Aloia TA , Brown AJ , et al.. Perioperative blood transfusion in gynecologic oncology surgery: analysis of the National Surgical Quality Improvement Program Database. Gynecol Oncol 2015;136:65–70.
Münstedt K , Kovacic M , Zygmunt M , et al.. Impact of hemoglobin levels before and during chemotherapy on survival of patients with ovarian cancer. Int J Oncol 2003;23:837–843.
Shin NR , Lee YY , Kim SH , et al.. Prognostic value of pretreatment hemoglobin level in patients with early cervical cancer. Obstet Gynecol Sci 2014;57:28–36.
Hierlihy P , Jenkin RD , Stryker JA . Anemia as a prognostic factor in cancer of the cervix: a preliminary report. Can Med Assoc J 1969;100:1100–1102.
Njølstad TS , Engerud H , Werner HMJ , et al.. Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas. Gynecol Oncol 2013;131:410–415.
Tamussino KF , Gücer F , Reich O , et al.. Pretreatment hemoglobin, platelet count, and prognosis in endometrial carcinoma. Int J Gynecol Cancer 2001;11:236–240.
Grogan M , Thomas GM , Melamed I , et al.. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 1999;86:1528–1536.
Roden DM , Pulley JM , Basford MA , et al.. Development of a large-scale de-identified DNA biobank to enable personalized medicine. Clin Pharmacol Ther 2008;84:362–369.
Denny JC , Bastarache L , Ritchie MD , et al.. Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data. Nat Biotechnol 2013;31:1102–1110.
National Cancer Institute. Common Terminology Criteria for Adverse Events (version 5.0). Accessed April 30, 2020. Available at: https://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm
Carson JL , Guyatt G , Heddle NM , et al.. Clinical practice guidelines from the AABB: red blood cell transfusion thresholds and storage. JAMA 2016;316:2025–2035.
Prescott LS , Taylor JS , Enbaya A , et al.. Choosing wisely: decreasing the incidence of perioperative blood transfusions in gynecologic oncology. Gynecol Oncol 2019;153:597–603.
Ludwig H , Van Belle S , Barrett-Lee P , et al.. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer 2004;40:2293–2306.
- Search Google Scholar
- Export Citation
. Ludwig H Van Belle S Barrett-Lee P The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer 2004; 40: 2293– 2306. 10.1016/j.ejca.2004.06.019 15454256
Busti F , Marchi G , Ugolini S , et al.. Anemia and iron deficiency in cancer patients: role of iron replacement therapy. Pharmaceuticals (Basel) 2018;11:94.
Xu H , Xu L , Page JH , et al.. Incidence of anemia in patients diagnosed with solid tumors receiving chemotherapy, 2010-2013. Clin Epidemiol 2016;8:61–71.
Rodgers GM , Gilreath JA . The role of intravenous iron in the treatment of anemia associated with cancer and chemotherapy. Acta Haematol 2019;142:13–20.
Ludwig H , Müldür E , Endler G , et al.. Prevalence of iron deficiency across different tumors and its association with poor performance status, disease status and anemia. Ann Oncol 2013;24:1886–1892.
Aapro M , Beguin Y , Bokemeyer C , et al.. Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines. Ann Oncol 2018;29 (Suppl 4):iv96–110.
Sapienza LG , Ning MS , Jhingran A , et al.. Short-course palliative radiation therapy leads to excellent bleeding control: a single centre retrospective study. Clin Transl Radiat Oncol 2018;14:40–46.
Dangsuwan P , Manchana T . Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy. Gynecol Oncol 2010;116:522–525.
Athibovonsuk P , Manchana T , Sirisabya N . Prevention of blood transfusion with intravenous iron in gynecologic cancer patients receiving platinum-based chemotherapy. Gynecol Oncol 2013;131:679–682.
Kim YT , Kim SW , Yoon BS , et al.. Effect of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients treated with concurrent chemoradiotherapy. Gynecol Oncol 2007;105:199–204.
- Search Google Scholar
- Export Citation
. Kim YT Kim SW Yoon BS Effect of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients treated with concurrent chemoradiotherapy. Gynecol Oncol 2007; 105: 199– 204. 10.1016/j.ygyno.2006.11.014 17234260
Steinmetz T , Totzke U , Schweigert M , et al.. A prospective observational study of anaemia management in cancer patients—results from the German Cancer Anaemia Registry. Eur J Cancer Care (Engl) 2011;20:493–502.
Steinmetz HT . The role of intravenous iron in the treatment of anemia in cancer patients. Ther Adv Hematol 2012;3:177–191.
Steinmetz T , Schröder J , Plath M , et al.. Antianemic treatment of cancer patients in German routine practice: data from a prospective cohort study—the Tumor Anemia Registry. Anemia 2016;2016:8057650.